| 30/09/26 | 13:00:00 | 30 Sept 2026 | | Interim Results for the Six Months to June 30, 2026, and Business Update | GNW |
| 25/09/26 | 07:00:00 | 25 Sept 2026 | | The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer | GNW |
| 16/09/26 | 16:00:00 | 16 Sept 2026 | | Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial | GNW |
| 14/09/26 | 07:00:00 | 14 Sept 2026 | | Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee | GNW |
| 08/07/26 | 07:00:00 | 8 Jul 2026 | | Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors | GNW |
| 01/06/26 | 07:00:00 | 1 Jun 2026 | | Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026 | GNW |
| 19/05/26 | 07:14:00 | 19 May 2026 | | Unaudited Preliminary Results for the Year Ended December 31, 2025 | GNW |
| 06/05/26 | 07:00:00 | 6 May 2026 | | Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 | GNW |
| 21/04/26 | 17:00:00 | 21 Apr 2026 | | Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform | GNW |
| 19/12/18 | 15:32:53 | 19 Dec 2018 | | Holding(s) in Company | RNS |
| 17/12/18 | 07:00:06 | 17 Dec 2018 | | Avacta London Science Day | RNS |
| 12/12/18 | 12:50:57 | 12 Dec 2018 | | Holding(s) in Company | RNS |
| 12/12/18 | 12:44:03 | 12 Dec 2018 | | Holding(s) in Company | RNS |
| 12/12/18 | 07:00:02 | 12 Dec 2018 | | Appointment of Chief Medical Officer | RNS |
| 11/12/18 | 07:00:12 | 11 Dec 2018 | | Posting of Annual Report and Notice of AGM | RNS |
| 10/12/18 | 14:05:41 | 10 Dec 2018 | | Second Price Monitoring Extn | RNS |
| 10/12/18 | 14:00:21 | 10 Dec 2018 | | Price Monitoring Extension | RNS |
| 10/12/18 | 07:00:04 | 10 Dec 2018 | | Development Partnership with LG Chem Life Sciences | RNS |
| 12/11/18 | 07:00:06 | 12 Nov 2018 | | Avacta to Present at Major European Conference | RNS |
| 11/10/18 | 08:00:09 | 11 Oct 2018 | | Avacta's CTO to Present at Major US Conference | RNS |
| 10/10/18 | 08:00:04 | 10 Oct 2018 | | Avacta agrees Affimer reagent licensing deal | RNS |
| 02/10/18 | 08:00:07 | 2 Oct 2018 | | Preliminary Results | RNS |
| 21/09/18 | 08:00:04 | 21 Sept 2018 | | Investor Meeting and Presentation | RNS |
| 05/09/18 | 08:00:15 | 5 Sept 2018 | | Notice of Results | RNS |
| 31/08/18 | 10:55:55 | 31 Aug 2018 | | Holding(s) in Company | RNS |
| 23/08/18 | 18:07:46 | 23 Aug 2018 | | Holding(s) in Company | RNS |
| 23/08/18 | 18:06:44 | 23 Aug 2018 | | Holding(s) in Company | RNS |
| 22/08/18 | 15:23:25 | 22 Aug 2018 | | Holding(s) in Company | RNS |
| 22/08/18 | 10:20:38 | 22 Aug 2018 | | Holding(s) in Company | RNS |
| 17/08/18 | 12:30:22 | 17 Aug 2018 | | Result of General Meeting | RNS |
| 06/08/18 | 17:24:09 | 6 Aug 2018 | | Holding(s) in Company | RNS |
| 30/07/18 | 19:06:33 | 30 Jul 2018 | | Results of Placing and Subscription | RNS |
| 30/07/18 | 12:41:43 | 30 Jul 2018 | | Proposed Placing and Subscription to raise £11.4m | RNS |
| 24/07/18 | 08:00:02 | 24 Jul 2018 | | Major Therapeutics Co-development Partnership | RNS |
| 11/06/18 | 08:00:04 | 11 Jun 2018 | | Appointment of Non-Executive Chairman | RNS |
| 22/05/18 | 08:00:02 | 22 May 2018 | | Successful Outcome of Study with FIT Biotech | RNS |
| 16/04/18 | 08:25:03 | 16 Apr 2018 | | Interim Results | RNS |
| 09/04/18 | 15:58:25 | 9 Apr 2018 | | Issue of Equity | RNS |
| 29/03/18 | 08:00:13 | 29 Mar 2018 | | Avacta to Present at Investor Forum | RNS |
| 29/03/18 | 08:00:10 | 29 Mar 2018 | | Directorate Change | RNS |
| 13/03/18 | 12:02:06 | 13 Mar 2018 | | Director/PDMR Shareholding | RNS |
| 07/03/18 | 16:35:11 | 7 Mar 2018 | | Price Monitoring Extension | RNS |
| 08/02/18 | 07:00:06 | 8 Feb 2018 | | Summary of Capital Markets Day | RNS |
| 22/01/18 | 07:00:03 | 22 Jan 2018 | | Avacta and OncoSec to Collaborate | RNS |
| 18/01/18 | 11:26:02 | 18 Jan 2018 | | Result of Annual General Meeting | RNS |
| 18/01/18 | 07:00:03 | 18 Jan 2018 | | AGM Business Update and Notice of Results | RNS |
| 15/01/18 | 10:58:13 | 15 Jan 2018 | | HardmanResearch: Affimer Drug Conjugates a reality | RNS |
| 15/01/18 | 07:00:03 | 15 Jan 2018 | | Drug Development Partnership with Glythera | RNS |
| 08/01/18 | 07:00:05 | 8 Jan 2018 | | Capital Markets Day Notification | RNS |
| 04/01/18 | 11:04:18 | 4 Jan 2018 | | PDMR Dealing and Issue of Equity | RNS |
